Enteral Feeding Formula Market: By Product Type (Standard formula & Disease specific formulas), By Application (Oncology, Gastroenterology, Neurology, Critical care) & By Region-Forecast (2016-2021)

  • ID: 3973869
  • Report
  • 140 pages
  • IndustryARC
1 of 4


  • Abbott Laboratories
  • B.Braun
  • Danone
  • Fresenius Kabi
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc.
  • MORE
Enteral feeding or tube feeding formulas is a dietary preparation delivering a nutritionally complete food with carbohydrate, protein, fat, water, minerals and vitamins, directly into the stomach, duodenum or jejunum when a patient cannot swallow food orally. Enteral feeding formulas are segmented into standard and disease-specific formulas. The standard formulas segment is further sub-divided into polymeric, monomeric formulas and specialized formulas. The disease-specific formulas are divided into pulmonary, diabetic, hepatic, renal and others (immune-enhancing, wound-healing and critical care).
Monomeric formulas contain a single nutrient, such as proteins, fats, or carbohydrates. It may be used alone to treat a specific deficiency or jointly with other formulas to completely suit nutritional requirements. Polymeric formulas include food and milk-based or lactose-free formulas and it is considered as balanced diet. Specialized formulas are expensive and contain hydrolyzed protein or sometimes amino acid formulas, which are generally used for patients with difficulty in digesting complex proteins.
The increasing prevalence of chronic diseases and preterm births, rapidly growing ageing population and increasing demand for homecare services, drive the market of enteral feeding formulas.
This report provides information on enteral feeding formulas market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to enteral feeding formulas market.

North America and Europe have major share in global enteral feeding formula market followed by Asia-Pacific and ROW. North America and Europe are the major markets with growing geriatric population and chronic diseases. Asia-Pacific markets are driven by increased prevalence of chronic diseases, rising healthcare spending and population in APAC countries.

This report identifies global enteral feeding formulas market on the basis of product type, therapeutic area and regional market as follows:

Enteral feeding formulas market based on product type is segmented into standard and disease-specific formulas
Based on therapeutic area gastroenterology, neurology, critical care and others

This report is further segmented based on regional potential markets for enteral feeding formulas. A detailed analysis by region – North America, Europe, Asia-Pacific (APAC) and Rest of the World (ROW), has been provided in this report

This report looks into all the major companies operating in the enteral feeding formula market. Some of the major companies’ profiles are as follows:

Abbott Laboratories
Nestlé S.A
Danone S.A
Fresenius Kabi AG
Mead Johnson Nutrition Company
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 4


  • Abbott Laboratories
  • B.Braun
  • Danone
  • Fresenius Kabi
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc.
  • MORE
1. Enteral Feeding Formula - Market Overview
2. Executive Summary
3. Enteral Feeding Formula - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Enteral Feeding Formula - Market Forces
4.1. Drivers
4.1.1. Rising prevalence of chronic diseases
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Customers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Enteral Feeding Formula Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Enteral Feeding Formula Market, By Product type
6.1. Standard formula
6.2. Disease specific formulas
7. Enteral Feeding Formula Market, By Therapeutic area
7.1. Oncology
7.2. Gastroenterology
7.3. Neurology
7.4. Critical care
7.5. Others
8. Enteral Feeding Formula Market, By Geography
8.1. Introduction
8.2. North America
8.2.1. US
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. U.K
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia Pacific
8.4.1. China
8.4.2. South Korea
8.4.3. Japan
8.4.4. India
8.4.5. Rest of Asia Pacific
8.5. RoW
9. Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply - Contract
10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
10.1. Abbott Laboratories
10.2. Nestle S.A.
10.3. Danone
10.4. Fresenius Kabi
10.5. Mead Johnson Nutrition Company
10.6. B.Braun
10.7. Victius Inc.
10.8. Meiji Holdings Co., Ltd.
10.9. Global Health Product Inc.
10.10. Merck & Co., Inc.
  • More than 40 Companies are profiled in this Research Report, Complete List available on Request -
" - Financials would be provided on a best efforts basis for private companies"
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Abbott Laboratories
Nestle S.A.
Fresenius Kabi
Mead Johnson Nutrition Company
Victius Inc.
Meiji Holdings Co., Ltd.
Global Health Product Inc.
Merck & Co., Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown